Kearny Venture Partners is a San Francisco, California–based venture capital firm focused exclusively on investing in emerging healthcare products, including medical devices, drugs, and related life science technologies. The firm manages over $300 million in capital and targets early through growth-stage opportunities where innovative solutions aim to address significant unmet clinical and market needs. Kearny typically participates in rounds across seed to later stages and collaborates with founders and co-investors to support development and commercialization of healthcare innovations. Its investment approach emphasizes deep sector expertise in life sciences and medical technologies. The firm is the successor to earlier healthcare-focused partnerships and engages actively with entrepreneurs and industry networks to advance products toward regulatory milestones and market adoption.